In terms of revenue, the Global Custom Antibody Market is expected to reach by 2030, growing at a CAGR (Compound Annual Growth Rate) of 9.75% from 2023 to 2030.
The global Custom Antibody market is poised to grow at a significant pace in the coming years, driven by several factors. The rising demand for personalized medicine and targeted therapies is expected to fuel the growth of the Custom Antibody market. With the increasing prevalence of chronic diseases such as cancer and autoimmune disorders, there is a growing need for targeted therapies that can effectively treat these diseases without affecting healthy cells. For instance, The Native Antigen Company develops, produces, and offers services to the biopharmaceutical and diagnostic industries in addition to producing antibodies and antigens. The company announced in December 2022 that it would broaden its portfolio of antigens and antibodies in the infectious diseases segment and develop a product to support the development of vaccines and immunoassays.
Companies are expected to expand their product portfolios more frequently, which will accelerate market expansion. Custom antibodies can play a critical role in the development of such therapies, as they can be designed to recognize and bind to specific molecules or cells. Another major driver of the Custom Antibody market is the increasing use of monoclonal antibodies in diagnostics and therapeutics. Monoclonal antibodies are highly specific and can be used to target a wide range of disease markers and antigens. Custom antibodies can be produced to target specific epitopes within these disease markers, increasing their specificity and efficacy.
Key Highlights from the Report
. Based on Type, the market for custom antibodies is dominated by monoclonal antibodies. These antibodies are made from a single type of immune cell and are made with a specific antigen in mind. They are the preferred option for numerous research and therapeutic applications due to their high specificity and affinities.
· Based on Service, since antibody development is the most popular service, it held the largest market share in 2022. Academic and research institutions, internal research divisions of pharmaceutical and biotechnology firms, and CROs are among the service providers. For instance, a December 2022 article described the work done by experts from the University of Texas Health Science Centre to develop antibodies to treat bone cancer and brain injuries.
· Based on Source, in 2022, the rabbit source had the highest market share for custom antibodies. The rabbit is an excellent choice for research on protein and peptide antigens because it is a frequent host in the production of antibodies. Technology is being developed by businesses to support the expansion of antibodies based on rabbits. For instance, one of the technologies on the market for creating custom monoclonal antibodies and capable of producing them in large quantities is GenScript's MonoRab. The fastest growth is anticipated for mice during the forecast. Rising supplier innovations to facilitate end-user R&D are credited with this growth.
· Based on Application, the market for custom antibodies continues to be dominated by the research sector. Research tools for understanding intricate biological processes and examining disease mechanisms include custom antibodies. Researchers can explore and examine a variety of biological molecules thanks to their use in various techniques like immunohistochemistry, flow cytometry, Western blotting, and ELISA.
·Based on End-User, the market share held by academic & research institutes in 2022 is expected to remain dominant due to its fast CAGR of 10%. The market is expected to experience significant growth due to the expansion of grant programs offered by businesses and regulatory bodies to promote Custom Antibody research. Regional governments, VCs, and businesses are some of the main sponsors for the research and development of custom antibodies.
· In terms of Region, North America held the major market share in 2022 and is likely to be the most gainful market in the future. The dominance of the area is due to the concentration of renowned research institutions, biopharmaceutical businesses, and cutting-edge healthcare infrastructure. Additionally, the largest market share for the production and use of custom antibodies is in North America, thanks to government funding for research initiatives and rising investments in the biotechnology industry.
The global Custom Antibody market is a rapidly growing industry that is expected to continue expanding at a significant rate in the coming years. Custom antibodies are created through the customization of antigen-specific antibodies, which are used to target specific structures within the cell or tissue. This customization allows for highly specific applications in areas like diagnostic testing, research, and therapeutic development. The market is being driven by several factors, including the increasing prevalence of chronic diseases, the growing demand for personalized medicines, and technological advancements in antibody development. Additionally, the rise of biotechnology and the emergence of new drug development paradigms are also expected to boost market growth.
The demand for custom antibodies is increasing as a result of technological developments and expanding application fields. The move towards personalized medicine, wherein unique antibodies play a crucial role in targeted therapies and diagnostics, is one of the market's most significant trends. The Custom Antibody market has a bright future, with chances to create next-generation antibodies that deliver more precise and efficient results. Additionally, the pharmaceutical industry's growing emphasis on biologics and monoclonal antibodies broadens the scope of Custom Antibody development, fostering a favorable environment for market expansion.
However, one of the major challenges faced by the market is the high cost associated with Custom Antibody development and production. This could limit the adoption of custom antibodies, particularly in emerging economies where cost is a major concern. Nevertheless, companies are investing in advanced technologies that can reduce the time and cost associated with Custom Antibody production.
North America Custom Antibody market is expected to witness a noteworthy development with a significant growth rate over the analysis period. Notable industry participants like Thermo Fisher Scientific Inc., Merck KGaA, Abcam plc, Bio-Rad Laboratories Inc., and GenScript Biotech Corporation are anticipated to accelerate market growth in the area. Additionally, the increasing prevalence of chronic diseases and the rising demand for personalized medicine also contribute to the market growth in North America. The United States is the major contributor to the growth of the Custom Antibody market in North America, driven by the presence of many key players, well-developed research infrastructure, and increasing R&D investments. Moreover, the growing demand for therapeutic antibodies, increasing use of custom antibodies in diagnostic assays, and rising demand for monoclonal antibodies in cancer and autoimmune disease treatments are also fueling the growth of the Custom Antibody market in this region. Furthermore, the increasing trend of outsourcing Custom Antibody production to contract research organizations (CROs) is also propelling the growth of the Custom Antibody market in North America.
The Global Custom Antibody Market is Segmented as follows
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- Other Types
- Antibody Development
- Antibody Production & Purification
- Antibody Fragmentation & Labeling
- Antibody Labeling
- Antibody Purification & Conjugation
- Antibody Engineering & Modification
- Other Services
- Other Sources
- Other Applications
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations
- Diagnostic Laboratories
- Other End-Users
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
List of the Key Players of the Global Custom Antibody Market is
Thermo Fisher Scientific Inc. (U.S.), Creative Diagnostics (U.S.), Abcam PLC (UK), Bio-Rad Laboratories Inc. (U.S.), Kaneka Eurogentec S.A. (Belgium), YenZym Antibodies LLC (U.S.), Abmart (China), Labcorp Drug Development (U.S.), LifeSpan BioSciences Inc. (U.S.), GenScript (U.S.)
The Global Custom Antibody Market Scope can be Tabulated below
|Market Size Provided for Years
|2017 - 2030
|2017 - 2021
|2023 - 2030
|Regions & Counties Covered
|Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis